Fernanda Maria Simões da Costa Fujino, Ana Amélia Campos Claro Olandim, Jennifer Anne Coggan, Antonio Deusany de Carvalho Junior, Adriana de Queiroz Soares Bufalo, Eduardo Nishimiya Takeyama, Soraya Cristina Sant'Ana, Vagner Doja Barnabé, Nilson Roberti Benites
{"title":"Homeopathic Treatment in Patients with COVID-19: Analysis of Clinical Evolution and Comparison between Cases in 2020 and 2021.","authors":"Fernanda Maria Simões da Costa Fujino, Ana Amélia Campos Claro Olandim, Jennifer Anne Coggan, Antonio Deusany de Carvalho Junior, Adriana de Queiroz Soares Bufalo, Eduardo Nishimiya Takeyama, Soraya Cristina Sant'Ana, Vagner Doja Barnabé, Nilson Roberti Benites","doi":"10.1055/s-0042-1749447","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong> The manifestations of coronavirus disease 2019 (COVID-19) can result in several prognoses and lead patients to look for appropriate complementary or alternative treatment options according to their personal situation and available health care. Patients with mild symptoms or those who have not yet reached the maximum severity of their condition are those who seek outpatient care, where homeopathic treatment might be considered, given the well documented history of this medical system in several epidemics in the past.</p><p><strong>Objective: </strong> The aim of this study was to compare the homeopathic treatment used for symptomatic cases of COVID-19 in March and April 2020 with cases treated in March and April 2021.</p><p><strong>Method: </strong> This is a retrospective observational study based on the analysis of the medical records of symptomatic COVID-19 patients treated on an outpatient basis with homeopathy at the Hahnemanniano George Galvão Institute in São Paulo, Brazil. We analyzed 54 cases, divided into two samples (27 cases in each year), similar in relation to age, gender and origin of the patients.</p><p><strong>Results: </strong> The development was distinct in the 2 years, with improvement of symptoms after 3 days of the first homeopathic prescription in 2020 whilst in 2021 the improvement occurred from the sixth day onward. The most frequently prescribed homeopathic medicine also differed in the two samples (<i>Antimonium tartaricum</i> in 2020; <i>Arsenicum album</i> in 2021), which indicates the different disease characteristics at these two moments of the epidemic.</p><p><strong>Conclusion: </strong> In 2020, the symptomatology of the cases was mainly acute and the main medicine was <i>Antimonium tartaricum</i>. By comparison, in 2021 a greater interference from individuals' previous chronic miasmatic disease may explain the change in the main medicines used that year, with <i>Arsenicum album</i> being the most prescribed in the cases studied.</p>","PeriodicalId":13227,"journal":{"name":"Homeopathy","volume":"112 1","pages":"3-11"},"PeriodicalIF":1.2000,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Homeopathy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1055/s-0042-1749447","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"INTEGRATIVE & COMPLEMENTARY MEDICINE","Score":null,"Total":0}
引用次数: 1
Abstract
Background: The manifestations of coronavirus disease 2019 (COVID-19) can result in several prognoses and lead patients to look for appropriate complementary or alternative treatment options according to their personal situation and available health care. Patients with mild symptoms or those who have not yet reached the maximum severity of their condition are those who seek outpatient care, where homeopathic treatment might be considered, given the well documented history of this medical system in several epidemics in the past.
Objective: The aim of this study was to compare the homeopathic treatment used for symptomatic cases of COVID-19 in March and April 2020 with cases treated in March and April 2021.
Method: This is a retrospective observational study based on the analysis of the medical records of symptomatic COVID-19 patients treated on an outpatient basis with homeopathy at the Hahnemanniano George Galvão Institute in São Paulo, Brazil. We analyzed 54 cases, divided into two samples (27 cases in each year), similar in relation to age, gender and origin of the patients.
Results: The development was distinct in the 2 years, with improvement of symptoms after 3 days of the first homeopathic prescription in 2020 whilst in 2021 the improvement occurred from the sixth day onward. The most frequently prescribed homeopathic medicine also differed in the two samples (Antimonium tartaricum in 2020; Arsenicum album in 2021), which indicates the different disease characteristics at these two moments of the epidemic.
Conclusion: In 2020, the symptomatology of the cases was mainly acute and the main medicine was Antimonium tartaricum. By comparison, in 2021 a greater interference from individuals' previous chronic miasmatic disease may explain the change in the main medicines used that year, with Arsenicum album being the most prescribed in the cases studied.
背景:2019冠状病毒病(COVID-19)的表现可导致多种预后，并导致患者根据个人情况和现有卫生保健寻求适当的补充或替代治疗方案。症状轻微的患者或病情尚未达到最大严重程度的患者应寻求门诊治疗，在那里可能考虑顺势疗法治疗，因为在过去的几次流行病中，顺势疗法医疗系统的历史记录良好。目的:比较2020年3月和4月与2021年3月和4月对COVID-19有症状病例的顺势疗法治疗。方法:本研究是一项回顾性观察性研究，基于对巴西圣保罗 Hahnemanniano George galv研究所门诊使用顺势疗法治疗的有症状的COVID-19患者的病历分析。我们分析了54例病例，分为两个样本(每年27例)，患者的年龄、性别和来源相似。结果:2年内的发展是明显的，2020年第一次顺势疗法处方3天后症状改善，而2021年从第六天开始改善。两种样本中最常用的顺势疗法药物也存在差异(2020年为酒石酸锑;砷(Arsenicum)专辑，这表明在这两个流行时刻的不同疾病特征。结论:2020年病例症状以急性为主，以酒石酸铵为主。相比之下，在2021年，来自个人以前的慢性瘴气疾病的更大干扰可能解释了当年使用的主要药物的变化，在研究的病例中，砷是处方最多的药物。
期刊介绍：
Homeopathy is an international peer-reviewed journal aimed at improving the fundamental understanding and clinical practice of homeopathy by publishing relevant high-quality original research articles, reviews, and case reports. It also promotes commentary and debate on matters of topical interest in homeopathy.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
